IGM Biosciences, Inc. Annual Depreciation in USD from 2017 to 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
IGM Biosciences, Inc. annual/quarterly Depreciation history and growth rate from 2017 to 2024.
  • IGM Biosciences, Inc. Depreciation for the quarter ending March 31, 2024 was $2.18M, a 30.8% increase year-over-year.
  • IGM Biosciences, Inc. annual Depreciation for 2024 was $9.11M, a 10.1% increase from 2023.
  • IGM Biosciences, Inc. annual Depreciation for 2023 was $8.28M, a 36.2% increase from 2022.
  • IGM Biosciences, Inc. annual Depreciation for 2022 was $6.08M, a 35.5% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $9.11M +$835K +10.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-06
2023 $8.28M +$2.2M +36.2% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-06
2022 $6.08M +$1.59M +35.5% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-06
2021 $4.48M +$3.46M +337% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-07
2020 $1.03M +$428K +71.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-30
2019 $597K +$319K +115% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-29
2018 $278K +$117K +72.7% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-30
2017 $161K Jan 1, 2017 Dec 31, 2017 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.